# Onconetix, Inc.: filings

ONCO · Nasdaq · CIK 1782107 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/onco.md) · [Financials](/companies/onco/financials.md) · [Filings](/companies/onco/filings.md) · [Insiders](/companies/onco/insiders.md)

## Reports and events: 196 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 120, 4 43, 3 25, CORRESP 21, S-1/A 18, UPLOAD 15, 10-Q 14, EFFECT 14, 425 12, S-1 12, 424B3 10, SC 13D 9, DEF 14A 8, 8-K/A 7, PRE 14A 6, 10-K 5, NT 10-Q 5, SC 13G 5, 424B4 4, PRER14A 4, S-8 4, D 3, DEFA14A 3, SCHEDULE 13D/A 3, FWP 2, NT 10-K 2, POS AM 2, SC 13G/A 2, SCHEDULE 13G 2, SEC STAFF LETTER 2, 3/A 1, 424B5 1, 8-A12B 1, ARS 1, CERT 1, DEF 14C 1, DRS 1, PRE 14C 1, S-3 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 17:04 ET | [8-K](/filings/0001213900-26-112527.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-112527 |
| 2026-10-23 | 11:40 ET | [8-K](/filings/0001213900-26-111944.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-111944 |
| 2026-10-07 | 11:29 ET | [DEF 14A](/filings/0001213900-26-107480.md) | Proxy statement, period 2026-11-10 | 0001213900-26-107480 |
| 2026-09-14 | 10:39 ET | [8-K](/filings/0001213900-26-099524.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-099524 |
| 2026-08-31 | 16:05 ET | [S-1/A](/filings/0001213900-26-095703.md) | Registration statement, amended | 0001213900-26-095703 |
| 2026-08-13 | 16:06 ET | [10-Q](/filings/0001213900-26-089093.md) | Quarterly report, period 2026-06-30 | 0001213900-26-089093 |
| 2026-08-12 | 13:52 ET | [S-1](/filings/0001213900-26-087986.md) | Registration statement | 0001213900-26-087986 |
| 2026-07-29 | 17:02 ET | [8-K](/filings/0001213900-26-082879.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-082879 |
| 2026-06-09 | 17:44 ET | [S-1](/filings/0001213900-26-066400.md) | Registration statement | 0001213900-26-066400 |
| 2026-05-19 | 16:05 ET | [8-K](/filings/0001213900-26-058997.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-058997 |
| 2026-05-14 | 20:35 ET | [8-K](/filings/0001213900-26-056109.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-056109 |
| 2026-05-13 | 08:51 ET | [10-Q](/filings/0001213900-26-055483.md) | Quarterly report, period 2026-03-31 | 0001213900-26-055483 |
| 2026-05-07 | 15:33 ET | [S-1/A](/filings/0001213900-26-053255.md) | Registration statement, amended | 0001213900-26-053255 |
| 2026-05-04 | 16:05 ET | [8-K](/filings/0001213900-26-051575.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-051575 |
| 2026-04-28 | 16:05 ET | [S-1](/filings/0001213900-26-048535.md) | Registration statement | 0001213900-26-048535 |
| 2026-04-24 | 16:32 ET | [8-K](/filings/0001213900-26-047577.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-047577 |
| 2026-03-30 | 08:47 ET | [DEF 14A](/filings/0001213900-26-035976.md) | Proxy statement, period 2026-04-30 | 0001213900-26-035976 |
| 2026-03-27 | 18:15 ET | [8-K](/filings/0001213900-26-034902.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-034902 |
| 2026-03-25 | 16:05 ET | [8-K/A](/filings/0001213900-26-034054.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-034054 |
| 2026-03-24 | 17:20 ET | [8-K](/filings/0001213900-26-033643.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-033643 |
| 2026-03-13 | 16:47 ET | [10-K](/filings/0001213900-26-027725.md) | Annual report, period 2025-12-31 | 0001213900-26-027725 |
| 2026-02-12 | 08:12 ET | [8-K](/filings/0001213900-26-015212.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-015212 |
| 2026-02-09 | 17:00 ET | [8-K](/filings/0001213900-26-013724.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-013724 |
| 2026-01-02 | 09:32 ET | [DEF 14A](/filings/0001213900-26-000080.md) | Proxy statement, period 2026-02-03 | 0001213900-26-000080 |
| 2025-12-22 | 18:50 ET | [S-1/A](/filings/0001213900-25-124018.md) | Registration statement, amended | 0001213900-25-124018 |
| 2025-12-10 | 17:00 ET | [8-K](/filings/0001213900-25-120144.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-120144 |
| 2025-12-10 | 09:28 ET | [8-K](/filings/0001213900-25-119898.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-119898 |
| 2025-11-13 | 17:26 ET | [10-Q](/filings/0001213900-25-110142.md) | Quarterly report, period 2025-09-30 | 0001213900-25-110142 |
| 2025-11-10 | 13:26 ET | [DEF 14A](/filings/0001213900-25-108093.md) | Proxy statement, period 2025-12-05 | 0001213900-25-108093 |
| 2025-11-04 | 16:40 ET | [S-1](/filings/0001213900-25-106177.md) | Registration statement | 0001213900-25-106177 |
| 2025-10-29 | 12:17 ET | [8-K](/filings/0001213900-25-103351.md) | 5.08 Item not in the standard list | 0001213900-25-103351 |
| 2025-10-16 | 21:24 ET | [S-1](/filings/0001213900-25-099298.md) | Registration statement | 0001213900-25-099298 |
| 2025-10-03 | 08:16 ET | [8-K](/filings/0001213900-25-095847.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-095847 |
| 2025-09-26 | 08:45 ET | [8-K](/filings/0001213900-25-091966.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-091966 |
| 2025-09-22 | 08:37 ET | [8-K](/filings/0001213900-25-089845.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-089845 |
| 2025-09-04 | 16:05 ET | [8-K](/filings/0001213900-25-084500.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-25-084500 |
| 2025-08-14 | 07:32 ET | [10-Q](/filings/0001213900-25-076032.md) | Quarterly report, period 2025-06-30 | 0001213900-25-076032 |
| 2025-08-12 | 16:06 ET | [8-K](/filings/0001213900-25-074952.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-074952 |
| 2025-07-16 | 16:03 ET | [SCHEDULE 13D/A](/filings/0001415889-25-019830.md) | Ownership report, active investor, amended | 0001415889-25-019830 |
| 2025-07-16 | 08:37 ET | [8-K](/filings/0001213900-25-064469.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-064469 |
| 2025-06-16 | 08:40 ET | [8-K](/filings/0001213900-25-054501.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-054501 |
| 2025-06-12 | 17:16 ET | [10-Q](/filings/0001213900-25-053914.md) | Quarterly report, period 2025-03-31 | 0001213900-25-053914 |
| 2025-06-11 | 13:00 ET | [8-K](/filings/0001213900-25-053367.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-053367 |
| 2025-06-05 | 16:12 ET | [8-K](/filings/0001213900-25-051573.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-051573 |
| 2025-06-02 | 07:41 ET | [10-K](/filings/0001213900-25-049687.md) | Annual report, period 2024-12-31 | 0001213900-25-049687 |
| 2025-05-22 | 17:10 ET | [8-K](/filings/0001213900-25-046909.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-25-046909 |
| 2025-04-30 | 17:23 ET | [8-K](/filings/0001213900-25-037765.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-25-037765 |
| 2025-04-30 | 18:50 ET | [DEF 14A](/filings/0001213900-25-036959.md) | Proxy statement, period 2025-05-30 | 0001213900-25-036959 |
| 2025-04-18 | 14:30 ET | [8-K](/filings/0001213900-25-033295.md) | 3.01 Delisting notice; 8.01 Other events | 0001213900-25-033295 |
| 2025-04-08 | 09:00 ET | [8-K](/filings/0001213900-25-029639.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-029639 |

Page 1 of 4. [Older](/companies/onco/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 08:32 ET. No prices; not investment advice.